News and Announcements
Actinogen Medical US Roadshow Investor Presentation July 2016
- Published July 15, 2016 12:03PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
15th July 2016, ASX Announcement
Focusing on an innovative approach, through the inhibition of cortisol production, for treating cognitive impairment in chronic neurodegenerative and metabolic diseases
Xanamem™: A prime investment opportunity
- Alzheimer’s – a significant unmet need in a huge and growing global market
- Xanamem™’s innovative, differentiated mechanism of action targeting the stress hormone cortisol
- Evidence Xanamem™ is both symptomatic and disease modifying
- Phase II study funded through to completion
- Patent protected to 2031 – composition of matter
- Value enhancing additional indications in substantive markets of interest to big pharmaceutical companies – Alzheimers disease, Diabetes, Parkinson’s disease
To view the full announcement, please click on the button below.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
